Review





Similar Products

94
Developmental Studies Hybridoma Bank anti ema 1
Anti Ema 1, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+surface+markers/pmc13000516-99-17-23?v=Developmental+Studies+Hybridoma+Bank
Average 94 stars, based on 1 article reviews
anti ema 1 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

95
Miltenyi Biotec surface stem cell marker tra1 60
Reprogramming of adult human dermal fibroblasts (HDFa) into induced pluripotent stem cell (iPSC) line BO-VC1. Reprogramming was performed using the Epi5 ™ Episomal iPSC Reprogramming Kit, enabling the generation of ( A ) transgene- and virus-free iPSC line BO-VC1. Successful generation of fibroblast-derived iPSCs was validated by immunocytochemical staining for the pluripotency markers ( B ) SOX2, C TRA 1–60, D OCT4, SSEA4 and E NANOG. Quantification of the generated iPSCs via flow cytometry revealed F 99.31% <t>SSEA4/TRA1-60,</t> G 97.43% SOX2/TRA1-60 and H 98.60% OCT3/4/TRA1-60 positive cells. I Quantification of the transcript levels of the stem cell markers NANOG , OCT4 , REX1 and SOX2 revealed significantly higher mRNA levels in iPSC line BO-VC1 compared to the HDFa control ( n = 3 different passages) Moreover, generated iPSCs were functionally validated by directed differentiation into all three germ layers. Subsequent immunocytochemical staining of the iPSCs before and after differentiation confirmed the expression of ( J–M ) meso-, N–Q endo- and R–U ectodermal lineage markers only in the respective differentiations. Scale bars: 50 μm. Data were tested for normal distribution using Shapiro-Wilk test. Means ± SEM (standard error of the mean) were statistically analyzed by a Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001)
Surface Stem Cell Marker Tra1 60, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+surface+markers/pmc13352860-130-13-20?v=Miltenyi+Biotec
Average 95 stars, based on 1 article reviews
surface stem cell marker tra1 60 - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

96
Miltenyi Biotec myogenic cell surface marker cd56
Reprogramming of adult human dermal fibroblasts (HDFa) into induced pluripotent stem cell (iPSC) line BO-VC1. Reprogramming was performed using the Epi5 ™ Episomal iPSC Reprogramming Kit, enabling the generation of ( A ) transgene- and virus-free iPSC line BO-VC1. Successful generation of fibroblast-derived iPSCs was validated by immunocytochemical staining for the pluripotency markers ( B ) SOX2, C TRA 1–60, D OCT4, SSEA4 and E NANOG. Quantification of the generated iPSCs via flow cytometry revealed F 99.31% <t>SSEA4/TRA1-60,</t> G 97.43% SOX2/TRA1-60 and H 98.60% OCT3/4/TRA1-60 positive cells. I Quantification of the transcript levels of the stem cell markers NANOG , OCT4 , REX1 and SOX2 revealed significantly higher mRNA levels in iPSC line BO-VC1 compared to the HDFa control ( n = 3 different passages) Moreover, generated iPSCs were functionally validated by directed differentiation into all three germ layers. Subsequent immunocytochemical staining of the iPSCs before and after differentiation confirmed the expression of ( J–M ) meso-, N–Q endo- and R–U ectodermal lineage markers only in the respective differentiations. Scale bars: 50 μm. Data were tested for normal distribution using Shapiro-Wilk test. Means ± SEM (standard error of the mean) were statistically analyzed by a Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001)
Myogenic Cell Surface Marker Cd56, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+surface+markers/bio_rxiv__64898__2026__04__12__717935-175-18-26?v=Miltenyi+Biotec
Average 96 stars, based on 1 article reviews
myogenic cell surface marker cd56 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

99
Sony Biotechnology surface marker cd45 cd11b 7 aad negative
Reprogramming of adult human dermal fibroblasts (HDFa) into induced pluripotent stem cell (iPSC) line BO-VC1. Reprogramming was performed using the Epi5 ™ Episomal iPSC Reprogramming Kit, enabling the generation of ( A ) transgene- and virus-free iPSC line BO-VC1. Successful generation of fibroblast-derived iPSCs was validated by immunocytochemical staining for the pluripotency markers ( B ) SOX2, C TRA 1–60, D OCT4, SSEA4 and E NANOG. Quantification of the generated iPSCs via flow cytometry revealed F 99.31% <t>SSEA4/TRA1-60,</t> G 97.43% SOX2/TRA1-60 and H 98.60% OCT3/4/TRA1-60 positive cells. I Quantification of the transcript levels of the stem cell markers NANOG , OCT4 , REX1 and SOX2 revealed significantly higher mRNA levels in iPSC line BO-VC1 compared to the HDFa control ( n = 3 different passages) Moreover, generated iPSCs were functionally validated by directed differentiation into all three germ layers. Subsequent immunocytochemical staining of the iPSCs before and after differentiation confirmed the expression of ( J–M ) meso-, N–Q endo- and R–U ectodermal lineage markers only in the respective differentiations. Scale bars: 50 μm. Data were tested for normal distribution using Shapiro-Wilk test. Means ± SEM (standard error of the mean) were statistically analyzed by a Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001)
Surface Marker Cd45 Cd11b 7 Aad Negative, supplied by Sony Biotechnology, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+surface+markers/pm41862768-315-18-27?v=Sony+Biotechnology
Average 99 stars, based on 1 article reviews
surface marker cd45 cd11b 7 aad negative - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

86
Valeant Pharmaceuticals cell surface marker dataset
Reprogramming of adult human dermal fibroblasts (HDFa) into induced pluripotent stem cell (iPSC) line BO-VC1. Reprogramming was performed using the Epi5 ™ Episomal iPSC Reprogramming Kit, enabling the generation of ( A ) transgene- and virus-free iPSC line BO-VC1. Successful generation of fibroblast-derived iPSCs was validated by immunocytochemical staining for the pluripotency markers ( B ) SOX2, C TRA 1–60, D OCT4, SSEA4 and E NANOG. Quantification of the generated iPSCs via flow cytometry revealed F 99.31% <t>SSEA4/TRA1-60,</t> G 97.43% SOX2/TRA1-60 and H 98.60% OCT3/4/TRA1-60 positive cells. I Quantification of the transcript levels of the stem cell markers NANOG , OCT4 , REX1 and SOX2 revealed significantly higher mRNA levels in iPSC line BO-VC1 compared to the HDFa control ( n = 3 different passages) Moreover, generated iPSCs were functionally validated by directed differentiation into all three germ layers. Subsequent immunocytochemical staining of the iPSCs before and after differentiation confirmed the expression of ( J–M ) meso-, N–Q endo- and R–U ectodermal lineage markers only in the respective differentiations. Scale bars: 50 μm. Data were tested for normal distribution using Shapiro-Wilk test. Means ± SEM (standard error of the mean) were statistically analyzed by a Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001)
Cell Surface Marker Dataset, supplied by Valeant Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+surface+markers/pm41857425-46-29-37?v=Valeant+Pharmaceuticals
Average 86 stars, based on 1 article reviews
cell surface marker dataset - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

86
Valeant Pharmaceuticals cell surface marker database
<t>Cell</t> <t>surface</t> <t>marker</t> identification. a Sankey diagram of workflow illustrating methods used to identify TIL compartment specific cell surface markers. Sensitivity and Specificity based analysis of putative cell surface markers across the TIL compartments using b Stem-Like, c Dysfunctional Effectors, or d GZMK+ Effectors as the group of interest. e 2D density plots demonstrating GZMK and GZMB in the compartments of interest. f Expression KLRG1 , ENTPD1 , and CD55 compared to all other compartments
Cell Surface Marker Database, supplied by Valeant Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+surface+markers/pmc13003044-111-17-21?v=Valeant+Pharmaceuticals
Average 86 stars, based on 1 article reviews
cell surface marker database - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

94
Elabscience Biotechnology cell surface markers
<t>Cell</t> <t>surface</t> <t>marker</t> identification. a Sankey diagram of workflow illustrating methods used to identify TIL compartment specific cell surface markers. Sensitivity and Specificity based analysis of putative cell surface markers across the TIL compartments using b Stem-Like, c Dysfunctional Effectors, or d GZMK+ Effectors as the group of interest. e 2D density plots demonstrating GZMK and GZMB in the compartments of interest. f Expression KLRG1 , ENTPD1 , and CD55 compared to all other compartments
Cell Surface Markers, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+surface+markers/pmc13069033-41-12-18?v=Elabscience+Biotechnology
Average 94 stars, based on 1 article reviews
cell surface markers - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

Image Search Results


Reprogramming of adult human dermal fibroblasts (HDFa) into induced pluripotent stem cell (iPSC) line BO-VC1. Reprogramming was performed using the Epi5 ™ Episomal iPSC Reprogramming Kit, enabling the generation of ( A ) transgene- and virus-free iPSC line BO-VC1. Successful generation of fibroblast-derived iPSCs was validated by immunocytochemical staining for the pluripotency markers ( B ) SOX2, C TRA 1–60, D OCT4, SSEA4 and E NANOG. Quantification of the generated iPSCs via flow cytometry revealed F 99.31% SSEA4/TRA1-60, G 97.43% SOX2/TRA1-60 and H 98.60% OCT3/4/TRA1-60 positive cells. I Quantification of the transcript levels of the stem cell markers NANOG , OCT4 , REX1 and SOX2 revealed significantly higher mRNA levels in iPSC line BO-VC1 compared to the HDFa control ( n = 3 different passages) Moreover, generated iPSCs were functionally validated by directed differentiation into all three germ layers. Subsequent immunocytochemical staining of the iPSCs before and after differentiation confirmed the expression of ( J–M ) meso-, N–Q endo- and R–U ectodermal lineage markers only in the respective differentiations. Scale bars: 50 μm. Data were tested for normal distribution using Shapiro-Wilk test. Means ± SEM (standard error of the mean) were statistically analyzed by a Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001)

Journal: Stem Cell Research & Therapy

Article Title: Activation of the G-protein coupled estrogen receptor 1 (GPER1) reduces transient receptor potential vanilloid 1 (TRPV1) activity and human iPSC-derived nociceptive neuron firing

doi: 10.1186/s13287-026-05174-3

Figure Lengend Snippet: Reprogramming of adult human dermal fibroblasts (HDFa) into induced pluripotent stem cell (iPSC) line BO-VC1. Reprogramming was performed using the Epi5 ™ Episomal iPSC Reprogramming Kit, enabling the generation of ( A ) transgene- and virus-free iPSC line BO-VC1. Successful generation of fibroblast-derived iPSCs was validated by immunocytochemical staining for the pluripotency markers ( B ) SOX2, C TRA 1–60, D OCT4, SSEA4 and E NANOG. Quantification of the generated iPSCs via flow cytometry revealed F 99.31% SSEA4/TRA1-60, G 97.43% SOX2/TRA1-60 and H 98.60% OCT3/4/TRA1-60 positive cells. I Quantification of the transcript levels of the stem cell markers NANOG , OCT4 , REX1 and SOX2 revealed significantly higher mRNA levels in iPSC line BO-VC1 compared to the HDFa control ( n = 3 different passages) Moreover, generated iPSCs were functionally validated by directed differentiation into all three germ layers. Subsequent immunocytochemical staining of the iPSCs before and after differentiation confirmed the expression of ( J–M ) meso-, N–Q endo- and R–U ectodermal lineage markers only in the respective differentiations. Scale bars: 50 μm. Data were tested for normal distribution using Shapiro-Wilk test. Means ± SEM (standard error of the mean) were statistically analyzed by a Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001)

Article Snippet: After harvesting, using Accutase, 1 × 10 6 cells were stained for the surface stem cell marker TRA1-60 (1:50, #130-122-965, Miltenyi Biotec, Bergisch Gladbach, Germany) and SSEA4 (1:50, #130-124-073, Miltenyi Biotec, Bergisch Gladbach, Germany) in 25 μl PEB buffer (PBS + 0.5% BSA) for 10 min at 4 °C, washed in 500 μl PEB buffer and centrifuged at 200xg for 5 min.

Techniques: Virus, Derivative Assay, Staining, Generated, Flow Cytometry, Control, Expressing

Cell surface marker identification. a Sankey diagram of workflow illustrating methods used to identify TIL compartment specific cell surface markers. Sensitivity and Specificity based analysis of putative cell surface markers across the TIL compartments using b Stem-Like, c Dysfunctional Effectors, or d GZMK+ Effectors as the group of interest. e 2D density plots demonstrating GZMK and GZMB in the compartments of interest. f Expression KLRG1 , ENTPD1 , and CD55 compared to all other compartments

Journal: Journal of Cancer Research and Clinical Oncology

Article Title: KLRG1 defines a distinct tumor-infiltrating granzyme K+ CD8 + T cell population

doi: 10.1007/s00432-026-06450-8

Figure Lengend Snippet: Cell surface marker identification. a Sankey diagram of workflow illustrating methods used to identify TIL compartment specific cell surface markers. Sensitivity and Specificity based analysis of putative cell surface markers across the TIL compartments using b Stem-Like, c Dysfunctional Effectors, or d GZMK+ Effectors as the group of interest. e 2D density plots demonstrating GZMK and GZMB in the compartments of interest. f Expression KLRG1 , ENTPD1 , and CD55 compared to all other compartments

Article Snippet: We first identified all differentially expressed genes specific to each compartment, then cross-referenced these with a curated cell surface marker database (Bausch-Fluck et al. ), yielding 175 potential candidates across the three populations of interest (Fig. A).

Techniques: Marker, Expressing

Surface marker validation a General flow gating strategy to identify CD3 + CD8+ TIL population from tumor suspensions and subsequent b surface and granzyme staining of each major TIL compartment in a representative patient sample. c Cell type proportion based on cell surface marker staining. d Median Fluorescence Intensity (MFI) of CD55 between granzyme negative cells vs. granzyme positive cells. e MFI of CD39 between GZMB- and GZMB+ cells. f MFI of KLRG1 between GZMK- and GZMK+ cells. g Fold enrichment of granzyme specific cell types following gating, with CD55 + cells enriching for granzyme negative cells, CD39 enriching for GZMB+ cells, and KLRG1 enriching for GZMK+ cells. h Scatter plot demonstrating correlation between original cell surface marker defined proportion of each cell type and the fold enrichment for the phenotypic cell type

Journal: Journal of Cancer Research and Clinical Oncology

Article Title: KLRG1 defines a distinct tumor-infiltrating granzyme K+ CD8 + T cell population

doi: 10.1007/s00432-026-06450-8

Figure Lengend Snippet: Surface marker validation a General flow gating strategy to identify CD3 + CD8+ TIL population from tumor suspensions and subsequent b surface and granzyme staining of each major TIL compartment in a representative patient sample. c Cell type proportion based on cell surface marker staining. d Median Fluorescence Intensity (MFI) of CD55 between granzyme negative cells vs. granzyme positive cells. e MFI of CD39 between GZMB- and GZMB+ cells. f MFI of KLRG1 between GZMK- and GZMK+ cells. g Fold enrichment of granzyme specific cell types following gating, with CD55 + cells enriching for granzyme negative cells, CD39 enriching for GZMB+ cells, and KLRG1 enriching for GZMK+ cells. h Scatter plot demonstrating correlation between original cell surface marker defined proportion of each cell type and the fold enrichment for the phenotypic cell type

Article Snippet: We first identified all differentially expressed genes specific to each compartment, then cross-referenced these with a curated cell surface marker database (Bausch-Fluck et al. ), yielding 175 potential candidates across the three populations of interest (Fig. A).

Techniques: Marker, Biomarker Discovery, Staining, Fluorescence